eMedCodes logo

BEXXAR - tositumomab I-131

Navigation: NDC > Supplier starting with: G > GLAXOSMITHKLINE LLC
Field Value
NDC Code: 0007-3262
Proprietary Name: BEXXAR
Suffix: THERAPEUTIC
Non-Proprietary Name: tositumomab I-131
Dosage Form: INJECTION
Method: INTRAVENOUS
Original Marketing Date: 15-07-2009
Category Name: BLA
Application Number: BLA125011
Labeler: GLAXOSMITHKLINE LLC
Substance Name: TOSITUMOMAB I-131
Active Numerator Strength: 5.6
Active Ingredient Unit: mCi/mL
Pharm Classes: CD20-directed Antibody Interactions [MoA],CD20-directed Radiotherapeutic Antibody [EPC],Radiopharmaceutical Activity [MoA]
DEA Schedule: